Tokyo Shinagawa Hospital
In research, Tokyo Shinagawa Hospital stands highest in Medicine (#14,884 of 17,978 worldwide) and Health Sciences (#17,889 of 20,462 worldwide), over all time.
- World rank, all time
- #33,897 of 42,892
- Rank in Japan
- #1,429 of 2,112
- Research works
- 232 ▼ 69% vs 2013–17
- Citations
- 5.7k 24.6 per fractional work
- Top-10% rate
- 15.4% record average 16.5%
- Open access
- 40% world 28%
What is Tokyo Shinagawa Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #14,884 of 17,978 | 11.4% | 186 | |
| Health SciencesDomain | #17,889 of 20,462 | 11.5% | 192 |
Each strip is that field’s whole ranked pool, with the notch where Tokyo Shinagawa Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 30.9×. Every wedge is a field page.
Who are the top researchers at Tokyo Shinagawa Hospital?
Ranked on the composite score, Kazuaki Takahashi and Shunji Mishiro lead among researchers whose main affiliation is Tokyo Shinagawa Hospital.
- 1 Kazuaki Takahashi Japan · #44,891 worldwide 302 citations · 57 works
- 2 Shunji Mishiro Japan · #136,377 worldwide 156 citations · 32 works
Which keywords describe research at Tokyo Shinagawa Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Immune Response, Antiviral Therapy, Liver Disease, Hepatocellular Carcinoma, Vaccine, Treatment and Pathogenesis.
- Circovirus
- Children
- Coronavirus
- Hepatic Encephalopathy
- Coagulopathy
- Norovirus
- Management
- NASH
- Hepatic Steatosis
- Metabolic Syndrome
- Chronic Infection
- Food Safety
- Pregnancy
- Diagnosis
- Hepatitis C Virus
- Chronic Hepatitis B
- Pathogenesis
- Vaccine
- Liver Disease
- Immune Response
- Epidemiology
- Antiviral Therapy
- Hepatocellular Carcinoma
- Treatment
- Global Burden
- Hepatitis B Virus
- Ribavirin
- Zoonotic Transmission
- Genetic Diversity
- Organ Transplant Recipients
- Hepatitis E Virus
- Insulin Resistance
- NAFLD
- Infection
- Clinical Practice Guidelines
- Rotavirus
- Immunosuppressive Therapy
- Liver Cirrhosis
- Genomic Sequencing
- Metagenomics
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology70▲ 7.4×69 topics
- Immune Response39▲ 27×14 topics
- Antiviral Therapy33▲ 93×3 topics
- Liver Disease32▲ 101×3 topics
- Hepatocellular Carcinoma29▲ 58×3 topics
- Vaccine26▲ 28×10 topics
- Treatment26▲ 8.6×21 topics
- Pathogenesis19▲ 15×13 topics
- Global Burden17▲ 14×4 topics
- Chronic Hepatitis B17▲ 136×1 topic
- Hepatitis B Virus17▲ 136×1 topic
- Hepatitis C Virus16▲ 128×1 topic
- Ribavirin16▲ 128×1 topic
- Diagnosis15▲ 6.3×26 topics
- Zoonotic Transmission15▲ 61×5 topics
- Pregnancy13▲ 26×5 topics
- Genetic Diversity12▲ 11×3 topics
- Food Safety12▲ 20×2 topics
- Organ Transplant Recipients12▲ 125×2 topics
- Chronic Infection12▲ 279×1 topic
- Hepatitis E Virus12▲ 279×1 topic
- Metabolic Syndrome12▲ 6.1×6 topics
- Insulin Resistance12▲ 11×6 topics
- Hepatic Steatosis11▲ 33×2 topics
- NAFLD11▲ 44×1 topic
- NASH11▲ 44×1 topic
- Infection9▲ 13×5 topics
- Management9▲ 4.8×15 topics
- Clinical Practice Guidelines8▲ 5.8×11 topics
- Norovirus7▲ 54×1 topic
- Rotavirus7▲ 54×1 topic
- Coagulopathy6▲ 33×2 topics
- Immunosuppressive Therapy6▲ 14×4 topics
- Hepatic Encephalopathy6▲ 45×1 topic
- Liver Cirrhosis6▲ 45×1 topic
- Coronavirus5▲ 20×3 topics
- Genomic Sequencing5▲ 15×3 topics
- Children5▲ 8.3×4 topics
- Metagenomics5▲ 17×2 topics
- Circovirus5▲ 55×1 topic
Which research topics does Tokyo Shinagawa Hospital publish most on?
By volume in 2022–2025: Renal Transplantation Outcomes and Treatments, Animal testing and alternatives, Dermatological diseases and infestations and Cardiac Imaging and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal Transplantation Outcomes and Treatments Transplantation 0 works
- 2 Animal testing and alternatives Small Animals 0 works
- 3 Dermatological diseases and infestations Infectious Diseases 0 works
- 4 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 0 works
- 5 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
- 6 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 0 works
- 7 Total Knee Arthroplasty Outcomes Surgery 0 works
- 8 Forensic Entomology and Diptera Studies Insect Science 0 works
- 9 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
- 10 Cervical and Thoracic Myelopathy Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tokyo Shinagawa Hospital's research output changed?
Output in 2018–2022 was 69% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.